Mirum Pharmaceuticals, Inc. (MIRM) › Operating IncomeMirum Pharmaceuticals, Inc. (MIRM) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$54.74M2020: -$104.30M2021: -$173.41M2022: -$131.22M2023: -$109.15M2024: -$87.61M2025: -$22.14M-$22.14M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$22.14M+74.7%2024-$87.61M+19.7%2023-$109.15M+16.8%2022-$131.22M+24.3%2021-$173.41M-66.3%2020-$104.30M-90.5%2019-$54.74M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share